Sign up to save your podcasts
Or
Share OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
129 Listeners
Global News Podcast
7,899 Listeners
Neurology® Podcast
273 Listeners
NEJM This Week
313 Listeners
Practical Neurology Podcast
35 Listeners
JAMA Clinical Reviews
488 Listeners
JAMA Neurology Author Interviews
13 Listeners
Annals On Call Podcast
169 Listeners
The Clinical Problem Solvers
506 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
317 Listeners
Neurology Exam Prep Podcast
176 Listeners
The Curious Clinicians
365 Listeners
The Lancet Neurology in conversation with
2 Listeners
Continuum Audio
75 Listeners